Skip to Main content Skip to Navigation
Journal articles

Alterations in myocardial energy metabolism induced by the anti-cancer drug doxorubicin.

Abstract : Doxorubicin and other anthracyclines are among the most potent chemotherapeutic drugs for the treatment of acute leukaemia, lymphomas and different types of solid tumours such as breast, liver and lung cancers. Their clinical use is, however, limited by the risk of severe cardiotoxicity, which can lead to irreversible congestive heart failure. There is increasing evidence that essential components of myocardial energy metabolism are among the highly sensitive and early targets of doxorubicin-induced damage. Here we review doxorubicin-induced detrimental changes in cardiac energetics, with an emphasis on the emerging importance of defects in energy-transferring and -signalling systems, like creatine kinase and AMP-activated protein kinase.
Document type :
Journal articles
Complete list of metadatas

https://www.hal.inserm.fr/inserm-00390889
Contributor : Sarah Hamant <>
Submitted on : Wednesday, June 3, 2009 - 12:06:42 AM
Last modification on : Wednesday, July 15, 2020 - 9:10:04 AM

Identifiers

Collections

LBFA | UGA

Citation

Malgorzata Tokarska-Schlattner, Théo Wallimann, Uwe Schlattner. Alterations in myocardial energy metabolism induced by the anti-cancer drug doxorubicin.. Comptes Rendus Biologies, Elsevier Masson, 2006, 329 (9), pp.657-68. ⟨10.1016/j.crvi.2005.08.007⟩. ⟨inserm-00390889⟩

Share

Metrics

Record views

209